Spotlighting cellular therapies to advance the treatment of medulloblastoma
- PMID: 36629263
- PMCID: PMC10076934
- DOI: 10.1093/neuonc/noad005
Spotlighting cellular therapies to advance the treatment of medulloblastoma
Conflict of interest statement
E.J.S. has pending patents related to vaccine technologies discussed in this editorial.
Figures
Comment on
-
Cellular immunotherapy for medulloblastoma.Neuro Oncol. 2023 Apr 6;25(4):617-627. doi: 10.1093/neuonc/noac236. Neuro Oncol. 2023. PMID: 36219688 Free PMC article. Review.